Rabbit Polyclonal Varicella Zoster Virus IE62 antibody. Suitable for ELISA, WB and reacts with Recombinant fragment - Human herpesvirus 2 samples. Cited in 1 publication.
View Alternative Names
Alpha 4 protein, IE175, Infected cell protein 4, Trans acting transcriptional protein ICP4, Transcriptional activator IE175, Transcriptional regulator ICP4
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ICP4 is essential to switch on the expression of viral genes during the lytic phase. It is not part of a complex but acts by binding directly to the viral DNA. The protein's function influences the viral lifecycle driving progression into the productive phase. By regulating gene expression ICP4 ensures viral proteins are synthesized in a timely manner during infection.
Pathways
ICP4 plays an instrumental role in the transcriptional activation of HSV2’s gene expression cascade. This pathway includes the viral immediate early (IE) early (E) and late (L) genes ensuring cycle progression. Besides ICP4 regulates interactions with other viral proteins like ICP0 and ICP27 which help maintain efficient replication and transcription processes in infected cells.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
BMC infectious diseases 20:832 PubMed33176697
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Associated Products
Alternative Product
Primary Antibodies
AB96431
Anti-HSV2 ICP4 antibody
primary-antibodies
hsv2-icp4-antibody-ab96431
4
(1 reviews)
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com